2020 Q4 Form 10-Q Financial Statement

#000162828020015977 Filed on November 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $7.826M $8.117M $9.832M
YoY Change -12.6% -17.44% 1.16%
Cost Of Revenue $3.190M $3.290M $6.040M
YoY Change -42.93% -45.53% 31.3%
Gross Profit $4.640M $4.830M $3.800M
YoY Change 38.1% 27.11% -25.49%
Gross Profit Margin 59.29% 59.5% 38.65%
Selling, General & Admin $2.110M $1.950M $1.680M
YoY Change 1.44% 16.07% -15.58%
% of Gross Profit 45.47% 40.37% 44.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.155M $2.262M $1.703M
YoY Change -3.71% 32.82% -19.78%
Operating Profit $2.485M $2.568M $2.097M
YoY Change 121.48% 22.46% -29.56%
Interest Expense $3.187M $3.285M $6.036M
YoY Change -42.98% -45.58% 31.1%
% of Operating Profit 128.25% 127.92% 287.84%
Other Income/Expense, Net -$54.00K -$162.0K -$202.0K
YoY Change -130.34% -19.8% -114.84%
Pretax Income $2.430M $2.410M $1.890M
YoY Change 85.5% 27.51% -56.55%
Income Tax -$39.00K -$142.6K -$267.0K
% Of Pretax Income -1.6% -5.92% -14.13%
Net Earnings $2.469M $2.551M $2.158M
YoY Change 102.05% 18.21% -50.42%
Net Earnings / Revenue 31.55% 31.43% 21.95%
Basic Earnings Per Share $0.10
Diluted Earnings Per Share $99.04K $0.10 $91.18K
COMMON SHARES
Basic Shares Outstanding 24.94M shares 24.94M shares 23.68M shares
Diluted Shares Outstanding 24.94M shares 23.69M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.40M $9.700M $10.30M
YoY Change 4.59% -5.83% 4.04%
Cash & Equivalents $11.38M $9.720M $10.30M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.40M $21.20M $12.50M
YoY Change 1.52% 69.6% -56.45%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $58.00M $14.50M $81.10M
YoY Change 1037.25% -82.12% 4.24%
Total Long-Term Assets $608.1M $616.6M $644.9M
YoY Change -5.68% -4.38% -1.11%
TOTAL ASSETS
Total Short-Term Assets $13.40M $21.20M $12.50M
Total Long-Term Assets $608.1M $616.6M $644.9M
Total Assets $621.5M $637.8M $657.4M
YoY Change -5.53% -2.97% -3.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $300.0K $500.0K $100.0K
YoY Change -25.0% 400.0% 0.0%
Accrued Expenses $400.0K $400.0K $800.0K
YoY Change -50.0% -50.0% -11.11%
Deferred Revenue
YoY Change
Short-Term Debt $463.1M $479.7M $505.4M
YoY Change -8.46% -5.09% 0.38%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $468.2M $483.8M $508.8M
YoY Change -8.18% -4.91% -0.04%
LONG-TERM LIABILITIES
Long-Term Debt $39.60M $39.50M $39.30M
YoY Change 0.51% 0.51% 101.54%
Other Long-Term Liabilities $300.0K $500.0K $100.0K
YoY Change -25.0% 400.0% -75.0%
Total Long-Term Liabilities $39.60M $39.50M $39.30M
YoY Change 0.51% 0.51% 97.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $468.2M $483.8M $508.8M
Total Long-Term Liabilities $39.60M $39.50M $39.30M
Total Liabilities $507.8M $523.3M $548.1M
YoY Change -7.55% -4.52% 3.67%
SHAREHOLDERS EQUITY
Retained Earnings $10.86M $8.392M $1.188M
YoY Change 350.58% 606.37% -128.36%
Common Stock $249.4K $249.4K $236.9K
YoY Change 5.28% 5.28% 0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $113.6M $114.4M $109.1M
YoY Change
Total Liabilities & Shareholders Equity $621.5M $637.8M $657.4M
YoY Change -5.53% -2.97% -3.45%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $2.469M $2.551M $2.158M
YoY Change 102.05% 18.21% -50.42%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $3.600M $3.470M $2.830M
YoY Change 69.81% 22.61% -46.3%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $60.77M $25.52M $40.25M
YoY Change -180.24% -36.6% -118.86%
Cash From Investing Activities $60.77M $25.52M $40.25M
YoY Change -180.24% -36.6% -118.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.25M -21.00M -1.770M
YoY Change 1019.19% 1086.44% -100.83%
NET CHANGE
Cash From Operating Activities 3.600M 3.470M 2.830M
Cash From Investing Activities 60.77M 25.52M 40.25M
Cash From Financing Activities -19.25M -21.00M -1.770M
Net Change In Cash 45.12M 7.990M 41.31M
YoY Change -159.89% -80.66% 555.71%
FREE CASH FLOW
Cash From Operating Activities $3.600M $3.470M $2.830M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001547546
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35845
dei Entity Registrant Name
EntityRegistrantName
HUNT COMPANIES FINANCE TRUST, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-4966519
dei Entity Address Address Line1
EntityAddressAddressLine1
230 Park Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
19th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10169
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
521-6323
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
HCFT
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24943383 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9720138 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10942115 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
14548916 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5069715 USD
CY2020Q3 us-gaap Notes Receivable Net
NotesReceivableNet
598933122 USD
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
635260420 USD
CY2020Q3 oaks Mortgage Service Rights At Fair Value
MortgageServiceRightsAtFairValue
1097154 USD
CY2019Q4 oaks Mortgage Service Rights At Fair Value
MortgageServiceRightsAtFairValue
2700207 USD
CY2020Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 USD
CY2019Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
40000 USD
CY2020Q3 us-gaap Interest Receivable
InterestReceivable
2280494 USD
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
2342354 USD
CY2020Q3 oaks Paydown Receivable
PaydownReceivable
9247423 USD
CY2019Q4 oaks Paydown Receivable
PaydownReceivable
0 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
2000279 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
1547187 USD
CY2020Q3 us-gaap Assets
Assets
637827526 USD
CY2019Q4 us-gaap Assets
Assets
657901998 USD
CY2020Q3 oaks Collateralized Loan Obligations
CollateralizedLoanObligations
479704710 USD
CY2019Q4 oaks Collateralized Loan Obligations
CollateralizedLoanObligations
505930065 USD
CY2020Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
39512924 USD
CY2019Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
39384041 USD
CY2020Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
411609 USD
CY2019Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
805126 USD
CY2020Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2123980 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1776912 USD
CY2020Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1115577 USD
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
991981 USD
CY2020Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
480562 USD
CY2019Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
369161 USD
CY2020Q3 us-gaap Liabilities
Liabilities
523349362 USD
CY2019Q4 us-gaap Liabilities
Liabilities
549257286 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24943383 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24943383 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23692164 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23692164 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
249389 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
236877 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
233847322 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
228135116 USD
CY2020Q3 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
128109631 USD
CY2019Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
122236981 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8391584 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2410200 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
114378664 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
108545212 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
99500 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
99500 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114478164 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
108644712 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
637827526 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
657901998 USD
CY2020Q3 us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
8111324 USD
CY2019Q3 us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
9825455 USD
us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
25749282 USD
us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
30018760 USD
CY2020Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
0 USD
CY2019Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
0 USD
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
0 USD
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
78361 USD
CY2020Q3 us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
5674 USD
CY2019Q3 us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
6551 USD
us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
41461 USD
us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
6551 USD
CY2019Q3 oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-444860 USD
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-1603052 USD
CY2020Q3 oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
2495996 USD
CY2019Q3 oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
5244001 USD
oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
9649523 USD
oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
16147178 USD
CY2020Q3 oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
789018 USD
CY2019Q3 oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
792121 USD
oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
2349900 USD
oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
1907348 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4831984 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3795884 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13791320 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12049146 USD
CY2020Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
CY2019Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-709439 USD
CY2020Q3 oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-350127 USD
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-1283977 USD
CY2020Q3 oaks Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts
UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts
0 USD
CY2019Q3 oaks Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts
UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts
0 USD
oaks Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts
UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts
0 USD
oaks Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts
UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts
694339 USD
CY2020Q3 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
187989 USD
CY2019Q3 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
243265 USD
us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
586516 USD
us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
676944 USD
CY2020Q3 us-gaap Other Income
OtherIncome
0 USD
CY2019Q3 us-gaap Other Income
OtherIncome
0 USD
us-gaap Other Income
OtherIncome
2 USD
us-gaap Other Income
OtherIncome
0 USD
CY2020Q3 oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-162138 USD
CY2019Q3 oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-201595 USD
oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-1016534 USD
oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-622133 USD
CY2019Q3 oaks Management And Incentive Fees
ManagementAndIncentiveFees
557833 USD
CY2020Q3 oaks Management And Incentive Fees
ManagementAndIncentiveFees
675107 USD
oaks Management And Incentive Fees
ManagementAndIncentiveFees
1850139 USD
oaks Management And Incentive Fees
ManagementAndIncentiveFees
1677456 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
786651 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
904413 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2531385 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3266757 USD
CY2020Q3 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
441349 USD
CY2019Q3 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
175174 USD
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
1249123 USD
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
1232211 USD
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-309125 USD
CY2019Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-19212 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1444049 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-204228 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
49199 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
46585 USD
us-gaap Share Based Compensation
ShareBasedCompensation
156093 USD
us-gaap Share Based Compensation
ShareBasedCompensation
146672 USD
CY2020Q3 us-gaap Noninterest Expense
NoninterestExpense
2261431 USD
CY2019Q3 us-gaap Noninterest Expense
NoninterestExpense
1703217 USD
us-gaap Noninterest Expense
NoninterestExpense
7230789 USD
us-gaap Noninterest Expense
NoninterestExpense
6527324 USD
CY2020Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
2408415 USD
CY2019Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
1891072 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
5543997 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
4899689 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-142595 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-266676 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-437387 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-126996 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2551010 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
2157748 USD
us-gaap Net Income Loss
NetIncomeLoss
5981384 USD
us-gaap Net Income Loss
NetIncomeLoss
5026685 USD
CY2020Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
3792 USD
CY2019Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
3792 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
11292 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
488056 USD
CY2020Q3 oaks Deemed Preferred Stock Dividend On Related Redemptions
DeemedPreferredStockDividendOnRelatedRedemptions
0 USD
CY2019Q3 oaks Deemed Preferred Stock Dividend On Related Redemptions
DeemedPreferredStockDividendOnRelatedRedemptions
0 USD
oaks Deemed Preferred Stock Dividend On Related Redemptions
DeemedPreferredStockDividendOnRelatedRedemptions
0 USD
oaks Deemed Preferred Stock Dividend On Related Redemptions
DeemedPreferredStockDividendOnRelatedRedemptions
3093028 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2547218 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2153956 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5970092 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1445601 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2547218 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2153956 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5970092 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1445601 USD
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24943383 shares
CY2019Q1 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
22383 USD
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23687664 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24931524 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23687664 shares
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.10
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.24
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.09
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
108644712 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5747375 USD
CY2020Q1 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
13333 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
7882 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1551671 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1870416 USD
CY2020Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3750 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114064141 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14985 USD
CY2020Q2 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
13333 USD
CY2020Q2 oaks Apic Share Based Payment Arrangement Restricted Stock Unit Decrease For Vesting
APICShareBasedPaymentArrangementRestrictedStockUnitDecreaseForVesting
8473 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1878703 USD
CY2020Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1870754 USD
CY2020Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3750 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114061519 USD
CY2020Q3 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
13334 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
2949 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2551010 USD
CY2020Q3 us-gaap Dividends Common Stock
DividendsCommonStock
2120188 USD
CY2020Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3792 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114478164 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
150203338 USD
CY2019Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
40250000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
3773 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1474767 USD
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1658136 USD
CY2019Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
480472 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
109270887 USD
CY2019Q2 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
22382 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
3814 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1394170 USD
CY2019Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1776575 USD
CY2019Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3792 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
108866122 USD
CY2019Q3 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
-15300 USD
CY2019Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
22385 USD
CY2019Q3 oaks Apic Share Based Payment Arrangement Restricted Stock Unit Decrease For Vesting
APICShareBasedPaymentArrangementRestrictedStockUnitDecreaseForVesting
14965 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
2157748 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
17343 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
7922 USD
CY2019Q3 us-gaap Dividends Common Stock
DividendsCommonStock
1776575 USD
CY2019Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3792 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
109221453 USD
us-gaap Net Income Loss
NetIncomeLoss
5981384 USD
us-gaap Net Income Loss
NetIncomeLoss
5026685 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-872869 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-819562 USD
oaks Amortization Of Offering Costs
AmortizationOfOfferingCosts
-40000 USD
oaks Amortization Of Offering Costs
AmortizationOfOfferingCosts
-67150 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
771017 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
755735 USD
oaks Realized Gain Loss On Sale Of Investments
RealizedGainLossOnSaleOfInvestments
0 USD
oaks Realized Gain Loss On Sale Of Investments
RealizedGainLossOnSaleOfInvestments
-709439 USD
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-1603052 USD
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-1283977 USD
oaks Unrealized Gain Loss On Multifamily Loans Held In Securitization Trust
UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrust
0 USD
oaks Unrealized Gain Loss On Multifamily Loans Held In Securitization Trust
UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrust
694339 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-61860 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-189977 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-40000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-67150 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
453092 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
467172 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-393517 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-52401 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
123596 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-439439 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
39675 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1981591 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8624187 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5158355 USD
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
52580443 USD
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
179075497 USD
oaks Repayments Of Principal To Repurchase Mortgage Loans Heldforsale
RepaymentsOfPrincipalToRepurchaseMortgageLoansHeldforsale
0 USD
oaks Repayments Of Principal To Repurchase Mortgage Loans Heldforsale
RepaymentsOfPrincipalToRepurchaseMortgageLoansHeldforsale
-4747049 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
88907741 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
174726836 USD
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
9247423 USD
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-33042234 USD
oaks Proceeds From Due To Affiliate
ProceedsFromDueToAffiliate
71727 USD
oaks Proceeds From Due To Affiliate
ProceedsFromDueToAffiliate
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27151602 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
33440622 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5747375 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
0 USD
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
40250000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5518082 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4855971 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
7500 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
528614 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
oaks Proceeds From Collateralized Loan Obligations
ProceedsFromCollateralizedLoanObligations
0 USD
oaks Proceeds From Collateralized Loan Obligations
ProceedsFromCollateralizedLoanObligations
0 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
40250000 USD
oaks Payment Of Collateralized Loan Obligations
PaymentOfCollateralizedLoanObligations
27740358 USD
oaks Payment Of Collateralized Loan Obligations
PaymentOfCollateralizedLoanObligations
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1090372 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27518565 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6474957 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8257224 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32124020 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16011830 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59213812 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24269054 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91337832 USD
us-gaap Interest Paid Net
InterestPaidNet
10747082 USD
us-gaap Interest Paid Net
InterestPaidNet
16531631 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
180898 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1956337 USD
CY2020Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2123980 USD
CY2019Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1780367 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. On March 11, 2020, the World Health Organization ("WHO") declared COVID-19 a global pandemic, which continues to spread throughout the United States and around the world. The outbreak has adversely impacted, and continues to adversely impact economic and market conditions globally, nationally and locally. Actions taken around the world to help mitigate the spread of COVID-19 include imposition of quarantines, "stay-at-home" orders, restrictions on travel and forced closures for certain types of public places, businesses and schools. The prolonged duration of the COVID-19 pandemic and its impact on our borrowers and their tenants, cash flows and future results of operations could be significant and will largely depend on future developments, which are highly uncertain and cannot be predicted. We believe the estimates and </span></div>assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of September 30, 2020, however uncertainty over the ultimate impact of COVID-19 on the global economy generally, and our business in particular, makes any estimates and assumptions inherently less certain than they would be absent the current and potential impacts of COVID-19. Actual results could differ from its estimates and the differences may be material.
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9720138 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10942115 USD
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24269054 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16011830 USD
CY2020Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
0 USD
CY2020Q3 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
0 USD
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0 USD
CY2020Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
1017419 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24943383 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24943383 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23692164 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23692164 shares
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2020Q3 oaks One Month Libor Rate
OneMonthLIBORRate
0.0016 USD
CY2019Q4 oaks One Month Libor Rate
OneMonthLIBORRate
0.0170 USD
CY2020Q3 oaks Weighted Average Libor Floor Rate
WeightedAverageLIBORFloorRate
0.0161 USD
CY2019Q4 oaks Weighted Average Libor Floor Rate
WeightedAverageLIBORFloorRate
0.0156 USD
CY2020Q3 oaks Average Risk Rate
AverageRiskRate
3.1
CY2019Q4 oaks Average Risk Rate
AverageRiskRate
2.8
CY2020Q1 oaks Number Of Loans Reclassified
NumberOfLoansReclassified
2 numberOfMulti-familyLoans
CY2018Q2 oaks Number Of Loan Participations
NumberOfLoanParticipations
8 Loan_Participation
CY2019Q1 oaks Collateralized Loan Obligation Unamortized Discount
CollateralizedLoanObligationUnamortizedDiscount
39200000 USD
CY2020Q3 oaks Collateralized Loan Obligation Deferred Financing Costs
CollateralizedLoanObligationDeferredFinancingCosts
737076 USD
CY2019Q4 oaks Collateralized Loan Obligation Deferred Financing Costs
CollateralizedLoanObligationDeferredFinancingCosts
865959 USD
CY2020Q3 us-gaap Secured Debt
SecuredDebt
40250000 USD
CY2020Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40250000 USD
CY2019Q4 us-gaap Secured Debt
SecuredDebt
40250000 USD
CY2019Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40250000 USD
CY2020Q3 us-gaap Secured Debt
SecuredDebt
40250000 USD
CY2020Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40250000 USD
CY2019Q4 us-gaap Secured Debt
SecuredDebt
40250000 USD
CY2019Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40250000 USD
CY2020Q3 oaks Number Of Licensed Sub Servicers
NumberOfLicensedSubServicers
2 numberOfMortgageSub-servicers
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1097154 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2700207 USD
CY2019 oaks Management Fee Percentage
ManagementFeePercentage
0.015
CY2019 oaks Quarterly Management Fee Percentage
QuarterlyManagementFeePercentage
0.00375
CY2020Q3 us-gaap Management Fee Expense
ManagementFeeExpense
588530 USD
CY2019Q3 us-gaap Management Fee Expense
ManagementFeeExpense
557833 USD
CY2020Q3 us-gaap Management Fee Payable
ManagementFeePayable
588000 USD
CY2019Q3 us-gaap Management Fee Payable
ManagementFeePayable
561000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
1763562 USD
us-gaap Management Fee Expense
ManagementFeeExpense
1677456 USD
CY2020Q3 us-gaap Management Fee Payable
ManagementFeePayable
588000 USD
CY2019Q3 us-gaap Management Fee Payable
ManagementFeePayable
561000 USD
CY2020Q3 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
441349 USD
CY2019Q3 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
175174 USD
CY2020Q3 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
441000 USD
CY2019Q3 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
174561 USD
CY2020Q3 oaks Exit Fee Waived Percentage Reduced
ExitFeeWaivedPercentageReduced
0.50
CY2019Q3 oaks Reimbursable Operating Expense Waived
ReimbursableOperatingExpenseWaived
345988 USD
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
1249123 USD
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
1232211 USD
CY2020Q3 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
441000 USD
CY2019Q3 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
174561 USD
oaks Exit Fee Waived Percentage Reduced
ExitFeeWaivedPercentageReduced
0.50
oaks Reimbursable Operating Expense Waived
ReimbursableOperatingExpenseWaived
73549 USD
oaks Reimbursable Operating Expense Waived
ReimbursableOperatingExpenseWaived
345988 USD
CY2020Q3 oaks Fair Value Investments Entities That Calculate Net Asset Value Per Share Funded
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareFunded
1800000 USD
CY2020Q3 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
29500000 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24943383 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24943383 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24943383 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23692164 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23692164 shares
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1610000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1610000 shares
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.0875
CY2018Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
25.00
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2551010 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
2157748 USD
CY2020Q3 us-gaap Dividends Common Stock
DividendsCommonStock
2120188 USD
CY2019Q3 us-gaap Dividends Common Stock
DividendsCommonStock
1776575 USD
CY2020Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3792 USD
CY2019Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3792 USD
CY2020Q3 us-gaap Dividends
Dividends
2123980 USD
CY2019Q3 us-gaap Dividends
Dividends
1780367 USD
CY2020Q3 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
427030 USD
CY2019Q3 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
377381 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24938883 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23683164 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4500 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4500 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24943383 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23687664 shares
us-gaap Net Income Loss
NetIncomeLoss
5981384 USD
us-gaap Net Income Loss
NetIncomeLoss
5026685 USD
us-gaap Dividends Common Stock
DividendsCommonStock
5861358 USD
us-gaap Dividends Common Stock
DividendsCommonStock
5211286 USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
11292 USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
488056 USD
oaks Deemed Preferred Stock Dividend On Related Redemptions
DeemedPreferredStockDividendOnRelatedRedemptions
0 USD
oaks Deemed Preferred Stock Dividend On Related Redemptions
DeemedPreferredStockDividendOnRelatedRedemptions
3093028 USD
us-gaap Dividends
Dividends
5872650 USD
us-gaap Dividends
Dividends
8792370 USD
us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
108734 USD
us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
-3765685 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24927122 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24927122 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23683164 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23683164 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4402 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4402 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4500 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4500 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24931524 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24931524 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23687664 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23687664 shares
CY2018Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
1960000 USD

Files In Submission

Name View Source Status
0001628280-20-015977-index-headers.html Edgar Link pending
0001628280-20-015977-index.html Edgar Link pending
0001628280-20-015977.txt Edgar Link pending
0001628280-20-015977-xbrl.zip Edgar Link pending
a20200930exhibit31-1.htm Edgar Link pending
a20200930exhibit31-2.htm Edgar Link pending
a20200930exhibit32-1.htm Edgar Link pending
a20200930exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
oaks-20200930.htm Edgar Link pending
oaks-20200930.xsd Edgar Link pending
oaks-20200930_cal.xml Edgar Link unprocessable
oaks-20200930_def.xml Edgar Link unprocessable
oaks-20200930_htm.xml Edgar Link completed
oaks-20200930_lab.xml Edgar Link unprocessable
oaks-20200930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending